Ontology type: schema:ScholarlyArticle Open Access: True
2021-01-06
AUTHORSGordon McGregor, Harbinder Sandhu, Julie Bruce, Bartholomew Sheehan, David McWilliams, Joyce Yeung, Christina Jones, Beatriz Lara, Jessica Smith, Chen Ji, Elaine Fairbrother, Stuart Ennis, Peter Heine, Sharisse Alleyne, Jonathan Guck, Emma Padfield, Rachel Potter, James Mason, Ranjit Lall, Kate Seers, Martin Underwood
ABSTRACTObjectivesThe primary objective is to determine which of two interventions: 1) an eight week, online, home-based, supervised, group rehabilitation programme (REGAIN); or 2) a single online session of advice (best-practice usual care); is the most clinically and cost-effective treatment for people with ongoing COVID-19 sequelae more than three months after hospital discharge.Trial designMulti-centre, 2-arm (1:1 ratio) parallel group, randomised controlled trial with embedded process evaluation and health economic evaluation.ParticipantsAdults with ongoing COVID-19 sequelae more than three months after hospital dischargeInclusion criteria: 1) Adults ≥18 years; 2) ≥ 3 months after any hospital discharge related to COVID-19 infection, regardless of need for critical care or ventilatory support; 3) substantial (as defined by the participant) COVID-19 related physical and/or mental health problems; 4) access to, and able/supported to use email and internet audio/video; 4) able to provide informed consent; 5) able to understand spoken and written English, Bengali, Gujarati, Urdu, Punjabi or Mandarin, themselves or supported by family/friends.Exclusion criteria: 1) exercise contraindicated; 2) severe mental health problems preventing engagement; 3) previous randomisation in the present study; 4) already engaged in, or planning to engage in an alternative NHS rehabilitation programme in the next 12 weeks; 5) a member of the same household previously randomised in the present study.Intervention and comparatorIntervention 1: The Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN (REGAIN) programme: an eight week, online, home-based, supervised, group rehabilitation programme.Intervention 2: A thirty-minute, on-line, one-to-one consultation with a REGAIN practitioner (best-practice usual care).Main outcomesThe primary outcome is health-related quality of life (HRQoL) – PROMIS® 29+2 Profile v2.1 (PROPr) – measured at three months post-randomisation.Secondary outcomes include dyspnoea, cognitive function, health utility, physical activity participation, post-traumatic stress disorder (PTSD) symptom severity, depressive and anxiety symptoms, work status, health and social care resource use, death - measured at three, six and 12 months post-randomisation.RandomisationParticipants will be randomised to best practice usual care or the REGAIN programme on a 1:1.03 basis using a computer-generated randomisation sequence, performed by minimisation and stratified by age, level of hospital care, and case level mental health symptomatology.Once consent and baseline questionnaires have been completed by the participant online at home, randomisation will be performed automatically by a bespoke web-based system.Blinding (masking)To ensure allocation concealment from both participant and REGAIN practitioner at baseline, randomisation will be performed only after the baseline questionnaires have been completed online at home by the participant. After randomisation has been performed, participants and REGAIN practitioners cannot be blind to group allocation. Follow-up outcome assessments will be completed by participants online at home.Numbers to be randomised (sample size)A total of 535 participants will be randomised: 263 to the best-practice usual care arm, and 272 participants to the REGAIN programme arm.Trial StatusCurrent protocol: Version 3.0 (27th October 2020) Recruitment will begin in December 2020 and is anticipated to complete by September 2021.Trial registrationISRCTN:11466448, 23rd November 2020Full protocolThe full protocol Version 3.0 (27th October 2020) is attached as an additional file, accessible from the Trials website (Additional file 1). In the interests of expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.The study protocol has been reported in accordance with the Standard Protocol Items: Recommendations for Clinical Interventional Trials (SPIRIT) guidelines. More... »
PAGES8
http://scigraph.springernature.com/pub.10.1186/s13063-020-04978-9
DOIhttp://dx.doi.org/10.1186/s13063-020-04978-9
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1134396148
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/33407804
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Public Health and Health Services",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "COVID-19",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cost-Benefit Analysis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Exercise Therapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Internet-Based Intervention",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Multicenter Studies as Topic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Psychosocial Support Systems",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Quality of Life",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Randomized Controlled Trials as Topic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Referral and Consultation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "SARS-CoV-2",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Severity of Illness Index",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "United Kingdom",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Centre for Sport, Exercise & Life Sciences, Coventry University, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.8096.7",
"name": [
"Department of Cardiopulmonary Rehabilitation, Centre for Exercise & Health, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK",
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"Centre for Sport, Exercise & Life Sciences, Coventry University, Coventry, UK"
],
"type": "Organization"
},
"familyName": "McGregor",
"givenName": "Gordon",
"id": "sg:person.01233634045.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233634045.14"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Sandhu",
"givenName": "Harbinder",
"id": "sg:person.0734523032.67",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734523032.67"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Bruce",
"givenName": "Julie",
"id": "sg:person.01255212333.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255212333.07"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Coventry & Warwickshire Partnership Trust, Coventry, UK",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Coventry & Warwickshire Partnership Trust, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Sheehan",
"givenName": "Bartholomew",
"id": "sg:person.010243472167.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010243472167.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Centre for Care Excellence, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.15628.38",
"name": [
"Centre for Care Excellence, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK"
],
"type": "Organization"
},
"familyName": "McWilliams",
"givenName": "David",
"id": "sg:person.01131751765.75",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131751765.75"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Anaesthesia and Critical Care, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK",
"id": "http://www.grid.ac/institutes/grid.412563.7",
"name": [
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"Department of Anaesthesia and Critical Care, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"
],
"type": "Organization"
},
"familyName": "Yeung",
"givenName": "Joyce",
"id": "sg:person.01160453144.93",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160453144.93"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "ICUSteps, Kemp House, London, UK",
"id": "http://www.grid.ac/institutes/None",
"name": [
"ICUSteps, Kemp House, London, UK"
],
"type": "Organization"
},
"familyName": "Jones",
"givenName": "Christina",
"id": "sg:person.010357720567.21",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010357720567.21"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Respiratory Medicine, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.15628.38",
"name": [
"Department of Respiratory Medicine, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Lara",
"givenName": "Beatriz",
"id": "sg:person.014740563567.08",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014740563567.08"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Smith",
"givenName": "Jessica",
"id": "sg:person.011223414367.51",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011223414367.51"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Ji",
"givenName": "Chen",
"id": "sg:person.01246242076.49",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246242076.49"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Patient & Public Involvement Representative, Coventry, UK",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Patient & Public Involvement Representative, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Fairbrother",
"givenName": "Elaine",
"id": "sg:person.013462051167.80",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013462051167.80"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Department of Cardiopulmonary Rehabilitation, Centre for Exercise & Health, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK",
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Ennis",
"givenName": "Stuart",
"id": "sg:person.011660466171.45",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011660466171.45"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Department of Cardiopulmonary Rehabilitation, Centre for Exercise & Health, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK",
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Heine",
"givenName": "Peter",
"id": "sg:person.0615465711.50",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615465711.50"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Alleyne",
"givenName": "Sharisse",
"id": "sg:person.014701743302.20",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014701743302.20"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Guck",
"givenName": "Jonathan",
"id": "sg:person.013000717167.21",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013000717167.21"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Padfield",
"givenName": "Emma",
"id": "sg:person.016564201567.78",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016564201567.78"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Potter",
"givenName": "Rachel",
"id": "sg:person.01306423733.58",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306423733.58"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Centre for Health Economics at Warwick, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Centre for Health Economics at Warwick, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Mason",
"givenName": "James",
"id": "sg:person.0700753524.38",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700753524.38"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Lall",
"givenName": "Ranjit",
"id": "sg:person.0713712645.25",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713712645.25"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Research in Nursing, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Warwick Research in Nursing, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Seers",
"givenName": "Kate",
"id": "sg:person.01045156011.03",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045156011.03"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK",
"id": "http://www.grid.ac/institutes/grid.7372.1",
"name": [
"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"
],
"type": "Organization"
},
"familyName": "Underwood",
"givenName": "Martin",
"id": "sg:person.01237606430.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237606430.13"
],
"type": "Person"
}
],
"datePublished": "2021-01-06",
"datePublishedReg": "2021-01-06",
"description": "ObjectivesThe primary objective is to determine which of two interventions: 1) an eight week, online, home-based, supervised, group rehabilitation programme (REGAIN); or 2) a single online session of advice (best-practice usual care); is the most clinically and cost-effective treatment for people with ongoing COVID-19 sequelae more than three months after hospital discharge.Trial designMulti-centre, 2-arm (1:1 ratio) parallel group, randomised controlled trial with embedded process evaluation and health economic evaluation.ParticipantsAdults with ongoing COVID-19 sequelae more than three months after hospital dischargeInclusion criteria: 1) Adults \u226518 years; 2) \u2265 3 months after any hospital discharge related to COVID-19 infection, regardless of need for critical care or ventilatory support; 3) substantial (as defined by the participant) COVID-19 related physical and/or mental health problems; 4) access to, and able/supported to use email and internet audio/video; 4) able to provide informed consent; 5) able to understand spoken and written English, Bengali, Gujarati, Urdu, Punjabi or Mandarin, themselves or supported by family/friends.Exclusion criteria: 1) exercise contraindicated; 2) severe mental health problems preventing engagement; 3) previous randomisation in the present study; 4) already engaged in, or planning to engage in an alternative NHS rehabilitation programme in the next 12 weeks; 5) a member of the same household previously randomised in the present study.Intervention and comparatorIntervention 1: The Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN (REGAIN) programme: an eight week, online, home-based, supervised, group rehabilitation programme.Intervention 2: A thirty-minute, on-line, one-to-one consultation with a REGAIN practitioner (best-practice usual care).Main outcomesThe primary outcome is health-related quality of life (HRQoL) \u2013 PROMIS\u00ae 29+2 Profile v2.1 (PROPr) \u2013 measured at three months post-randomisation.Secondary outcomes include dyspnoea, cognitive function, health utility, physical activity participation, post-traumatic stress disorder (PTSD) symptom severity, depressive and anxiety symptoms, work status, health and social care resource use, death - measured at three, six and 12 months post-randomisation.RandomisationParticipants will be randomised to best practice usual care or the REGAIN programme on a 1:1.03 basis using a computer-generated randomisation sequence, performed by minimisation and stratified by age, level of hospital care, and case level mental health symptomatology.Once consent and baseline questionnaires have been completed by the participant online at home, randomisation will be performed automatically by a bespoke web-based system.Blinding (masking)To ensure allocation concealment from both participant and REGAIN practitioner at baseline, randomisation will be performed only after the baseline questionnaires have been completed online at home by the participant. After randomisation has been performed, participants and REGAIN practitioners cannot be blind to group allocation. Follow-up outcome assessments will be completed by participants online at home.Numbers to be randomised (sample size)A total of 535 participants will be randomised: 263 to the best-practice usual care arm, and 272 participants to the REGAIN programme arm.Trial StatusCurrent protocol: Version 3.0 (27th October 2020) Recruitment will begin in December 2020 and is anticipated to complete by September 2021.Trial registrationISRCTN:11466448, 23rd November 2020Full protocolThe full protocol Version 3.0 (27th October 2020) is attached as an additional file, accessible from the Trials website (Additional file 1). In the interests of expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.The study protocol has been reported in accordance with the Standard Protocol Items: Recommendations for Clinical Interventional Trials (SPIRIT) guidelines.",
"genre": "article",
"id": "sg:pub.10.1186/s13063-020-04978-9",
"inLanguage": "en",
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.9613934",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1297400",
"issn": [
"1468-6708",
"1745-6215"
],
"name": "Trials",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "22"
}
],
"keywords": [
"group rehabilitation programme",
"COVID-19 sequelae",
"COVID-19 infection",
"mental health problems",
"rehabilitation program",
"hospital discharge",
"baseline questionnaire",
"study protocol",
"health problems",
"social care resource use",
"computer-generated randomisation sequence",
"rehabilitation exercises",
"embedded process evaluation",
"Interventional Trials guidelines",
"usual care arm",
"psychological support",
"health-related quality",
"care resource use",
"post-traumatic stress disorder symptom severity",
"Standard Protocol Items",
"severe mental health problems",
"mental health symptomatology",
"physical activity participation",
"health economic evaluations",
"cost-effective treatment",
"ObjectivesThe primary objective",
"family/friends",
"care arm",
"ventilatory support",
"usual care",
"randomisation sequence",
"Secondary outcomes",
"primary outcome",
"allocation concealment",
"Trials website",
"present study",
"Trials guidelines",
"parallel group",
"Infections Program",
"critical care",
"hospital care",
"health utility",
"group allocation",
"disorder symptom severity",
"Protocol Items",
"outcome assessment",
"randomisation",
"symptom severity",
"cognitive function",
"informed consent",
"program arm",
"months",
"work status",
"thirty minutes",
"anxiety symptoms",
"process evaluation",
"trials",
"weeks",
"care",
"sequelae",
"COVID-19",
"activity participation",
"infection",
"same household",
"full protocol",
"exercise",
"version 3.0",
"participants",
"intervention",
"outcomes",
"primary objective",
"economic evaluation",
"consent",
"structured summary",
"questionnaire",
"ParticipantsAdults",
"home",
"arm",
"symptoms",
"resource use",
"symptomatology",
"baseline",
"severity",
"protocol",
"practitioners",
"adults",
"age",
"treatment",
"consultation",
"total",
"discharge",
"evaluation",
"summary",
"study",
"health",
"program",
"online sessions",
"status",
"guidelines",
"sessions",
"group",
"years",
"support",
"recruitment",
"advice",
"dissemination",
"assessment",
"levels",
"recommendations",
"criteria",
"web-based system",
"v2.1",
"utility",
"people",
"concealment",
"objective",
"need",
"use",
"items",
"function",
"samples",
"key elements",
"access",
"quality",
"members",
"participation",
"friends",
"lines",
"number",
"email",
"Punjabi",
"households",
"accordance",
"engagement",
"files",
"planning",
"websites",
"English",
"basis",
"additional files",
"interest",
"Gujarati",
"materials",
"problem",
"Urdu",
"sequence",
"Mandarin",
"system",
"formatting",
"audio/video",
"video",
"allocation",
"letter",
"minimisation",
"elements",
"Bengali"
],
"name": "Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN\u2019 (REGAIN): a structured summary of a study protocol for a randomised controlled trial",
"pagination": "8",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1134396148"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s13063-020-04978-9"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"33407804"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s13063-020-04978-9",
"https://app.dimensions.ai/details/publication/pub.1134396148"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:38",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_886.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/s13063-020-04978-9"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13063-020-04978-9'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13063-020-04978-9'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13063-020-04978-9'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13063-020-04978-9'
This table displays all metadata directly associated to this object as RDF triples.
458 TRIPLES
21 PREDICATES
200 URIs
191 LITERALS
24 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1186/s13063-020-04978-9 | schema:about | N0d26e3b5945d43f6a97893f7221b7653 |
2 | ″ | ″ | N13ba09f8cbed4231acecad51b079eb34 |
3 | ″ | ″ | N15a7522317cc4394989a45305f32ba12 |
4 | ″ | ″ | N1c7f8897ae9a40ffb427e38c558e5b84 |
5 | ″ | ″ | N22d6066a6ea94cba8ab5f23e8984bf78 |
6 | ″ | ″ | N355e0d2fa3f84b1c90098149f8b27ba4 |
7 | ″ | ″ | N3735dd1716f94ce5988ce431deb8afcf |
8 | ″ | ″ | N470a9988d41b4ead9d5eb7685cb4566a |
9 | ″ | ″ | N4a7f145bf9f1439a849f63867bd07f01 |
10 | ″ | ″ | N79a258beb5974ab9ab1ebd590e0a978d |
11 | ″ | ″ | N7a024ac39b62440a8212234a4e13dc9d |
12 | ″ | ″ | N7aa9f214aba04eada24eafb2990bd6bf |
13 | ″ | ″ | N8913d27f73734ccca79baaf7915abad2 |
14 | ″ | ″ | N98092d922f0f4afe9f8833fd52d0ed7e |
15 | ″ | ″ | Nc0ba816774c54ca48c04fdeee75e6d1d |
16 | ″ | ″ | Nd2702ab4846949ae8ea3f175dd2732bc |
17 | ″ | ″ | Nd6cef0aeda184dc190db78152c49f9fe |
18 | ″ | ″ | anzsrc-for:11 |
19 | ″ | ″ | anzsrc-for:1103 |
20 | ″ | ″ | anzsrc-for:1117 |
21 | ″ | schema:author | N586191abdeb1438da99d8d6c6e8609d2 |
22 | ″ | schema:datePublished | 2021-01-06 |
23 | ″ | schema:datePublishedReg | 2021-01-06 |
24 | ″ | schema:description | ObjectivesThe primary objective is to determine which of two interventions: 1) an eight week, online, home-based, supervised, group rehabilitation programme (REGAIN); or 2) a single online session of advice (best-practice usual care); is the most clinically and cost-effective treatment for people with ongoing COVID-19 sequelae more than three months after hospital discharge.Trial designMulti-centre, 2-arm (1:1 ratio) parallel group, randomised controlled trial with embedded process evaluation and health economic evaluation.ParticipantsAdults with ongoing COVID-19 sequelae more than three months after hospital dischargeInclusion criteria: 1) Adults ≥18 years; 2) ≥ 3 months after any hospital discharge related to COVID-19 infection, regardless of need for critical care or ventilatory support; 3) substantial (as defined by the participant) COVID-19 related physical and/or mental health problems; 4) access to, and able/supported to use email and internet audio/video; 4) able to provide informed consent; 5) able to understand spoken and written English, Bengali, Gujarati, Urdu, Punjabi or Mandarin, themselves or supported by family/friends.Exclusion criteria: 1) exercise contraindicated; 2) severe mental health problems preventing engagement; 3) previous randomisation in the present study; 4) already engaged in, or planning to engage in an alternative NHS rehabilitation programme in the next 12 weeks; 5) a member of the same household previously randomised in the present study.Intervention and comparatorIntervention 1: The Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN (REGAIN) programme: an eight week, online, home-based, supervised, group rehabilitation programme.Intervention 2: A thirty-minute, on-line, one-to-one consultation with a REGAIN practitioner (best-practice usual care).Main outcomesThe primary outcome is health-related quality of life (HRQoL) – PROMIS® 29+2 Profile v2.1 (PROPr) – measured at three months post-randomisation.Secondary outcomes include dyspnoea, cognitive function, health utility, physical activity participation, post-traumatic stress disorder (PTSD) symptom severity, depressive and anxiety symptoms, work status, health and social care resource use, death - measured at three, six and 12 months post-randomisation.RandomisationParticipants will be randomised to best practice usual care or the REGAIN programme on a 1:1.03 basis using a computer-generated randomisation sequence, performed by minimisation and stratified by age, level of hospital care, and case level mental health symptomatology.Once consent and baseline questionnaires have been completed by the participant online at home, randomisation will be performed automatically by a bespoke web-based system.Blinding (masking)To ensure allocation concealment from both participant and REGAIN practitioner at baseline, randomisation will be performed only after the baseline questionnaires have been completed online at home by the participant. After randomisation has been performed, participants and REGAIN practitioners cannot be blind to group allocation. Follow-up outcome assessments will be completed by participants online at home.Numbers to be randomised (sample size)A total of 535 participants will be randomised: 263 to the best-practice usual care arm, and 272 participants to the REGAIN programme arm.Trial StatusCurrent protocol: Version 3.0 (27th October 2020) Recruitment will begin in December 2020 and is anticipated to complete by September 2021.Trial registrationISRCTN:11466448, 23rd November 2020Full protocolThe full protocol Version 3.0 (27th October 2020) is attached as an additional file, accessible from the Trials website (Additional file 1). In the interests of expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.The study protocol has been reported in accordance with the Standard Protocol Items: Recommendations for Clinical Interventional Trials (SPIRIT) guidelines. |
25 | ″ | schema:genre | article |
26 | ″ | schema:inLanguage | en |
27 | ″ | schema:isAccessibleForFree | true |
28 | ″ | schema:isPartOf | N8718a97f4b4d48fe935fb913bd3653ed |
29 | ″ | ″ | Nac7ca32b35814e0abb46364f7df3ccde |
30 | ″ | ″ | sg:journal.1297400 |
31 | ″ | schema:keywords | Bengali |
32 | ″ | ″ | COVID-19 |
33 | ″ | ″ | COVID-19 infection |
34 | ″ | ″ | COVID-19 sequelae |
35 | ″ | ″ | English |
36 | ″ | ″ | Gujarati |
37 | ″ | ″ | Infections Program |
38 | ″ | ″ | Interventional Trials guidelines |
39 | ″ | ″ | Mandarin |
40 | ″ | ″ | ObjectivesThe primary objective |
41 | ″ | ″ | ParticipantsAdults |
42 | ″ | ″ | Protocol Items |
43 | ″ | ″ | Punjabi |
44 | ″ | ″ | Secondary outcomes |
45 | ″ | ″ | Standard Protocol Items |
46 | ″ | ″ | Trials guidelines |
47 | ″ | ″ | Trials website |
48 | ″ | ″ | Urdu |
49 | ″ | ″ | access |
50 | ″ | ″ | accordance |
51 | ″ | ″ | activity participation |
52 | ″ | ″ | additional files |
53 | ″ | ″ | adults |
54 | ″ | ″ | advice |
55 | ″ | ″ | age |
56 | ″ | ″ | allocation |
57 | ″ | ″ | allocation concealment |
58 | ″ | ″ | anxiety symptoms |
59 | ″ | ″ | arm |
60 | ″ | ″ | assessment |
61 | ″ | ″ | audio/video |
62 | ″ | ″ | baseline |
63 | ″ | ″ | baseline questionnaire |
64 | ″ | ″ | basis |
65 | ″ | ″ | care |
66 | ″ | ″ | care arm |
67 | ″ | ″ | care resource use |
68 | ″ | ″ | cognitive function |
69 | ″ | ″ | computer-generated randomisation sequence |
70 | ″ | ″ | concealment |
71 | ″ | ″ | consent |
72 | ″ | ″ | consultation |
73 | ″ | ″ | cost-effective treatment |
74 | ″ | ″ | criteria |
75 | ″ | ″ | critical care |
76 | ″ | ″ | discharge |
77 | ″ | ″ | disorder symptom severity |
78 | ″ | ″ | dissemination |
79 | ″ | ″ | economic evaluation |
80 | ″ | ″ | elements |
81 | ″ | ″ | |
82 | ″ | ″ | embedded process evaluation |
83 | ″ | ″ | engagement |
84 | ″ | ″ | evaluation |
85 | ″ | ″ | exercise |
86 | ″ | ″ | family/friends |
87 | ″ | ″ | files |
88 | ″ | ″ | formatting |
89 | ″ | ″ | friends |
90 | ″ | ″ | full protocol |
91 | ″ | ″ | function |
92 | ″ | ″ | group |
93 | ″ | ″ | group allocation |
94 | ″ | ″ | group rehabilitation programme |
95 | ″ | ″ | guidelines |
96 | ″ | ″ | health |
97 | ″ | ″ | health economic evaluations |
98 | ″ | ″ | health problems |
99 | ″ | ″ | health utility |
100 | ″ | ″ | health-related quality |
101 | ″ | ″ | home |
102 | ″ | ″ | hospital care |
103 | ″ | ″ | hospital discharge |
104 | ″ | ″ | households |
105 | ″ | ″ | infection |
106 | ″ | ″ | informed consent |
107 | ″ | ″ | interest |
108 | ″ | ″ | intervention |
109 | ″ | ″ | items |
110 | ″ | ″ | key elements |
111 | ″ | ″ | letter |
112 | ″ | ″ | levels |
113 | ″ | ″ | lines |
114 | ″ | ″ | materials |
115 | ″ | ″ | members |
116 | ″ | ″ | mental health problems |
117 | ″ | ″ | mental health symptomatology |
118 | ″ | ″ | minimisation |
119 | ″ | ″ | months |
120 | ″ | ″ | need |
121 | ″ | ″ | number |
122 | ″ | ″ | objective |
123 | ″ | ″ | online sessions |
124 | ″ | ″ | outcome assessment |
125 | ″ | ″ | outcomes |
126 | ″ | ″ | parallel group |
127 | ″ | ″ | participants |
128 | ″ | ″ | participation |
129 | ″ | ″ | people |
130 | ″ | ″ | physical activity participation |
131 | ″ | ″ | planning |
132 | ″ | ″ | post-traumatic stress disorder symptom severity |
133 | ″ | ″ | practitioners |
134 | ″ | ″ | present study |
135 | ″ | ″ | primary objective |
136 | ″ | ″ | primary outcome |
137 | ″ | ″ | problem |
138 | ″ | ″ | process evaluation |
139 | ″ | ″ | program |
140 | ″ | ″ | program arm |
141 | ″ | ″ | protocol |
142 | ″ | ″ | psychological support |
143 | ″ | ″ | quality |
144 | ″ | ″ | questionnaire |
145 | ″ | ″ | randomisation |
146 | ″ | ″ | randomisation sequence |
147 | ″ | ″ | recommendations |
148 | ″ | ″ | recruitment |
149 | ″ | ″ | rehabilitation exercises |
150 | ″ | ″ | rehabilitation program |
151 | ″ | ″ | resource use |
152 | ″ | ″ | same household |
153 | ″ | ″ | samples |
154 | ″ | ″ | sequelae |
155 | ″ | ″ | sequence |
156 | ″ | ″ | sessions |
157 | ″ | ″ | severe mental health problems |
158 | ″ | ″ | severity |
159 | ″ | ″ | social care resource use |
160 | ″ | ″ | status |
161 | ″ | ″ | structured summary |
162 | ″ | ″ | study |
163 | ″ | ″ | study protocol |
164 | ″ | ″ | summary |
165 | ″ | ″ | support |
166 | ″ | ″ | symptom severity |
167 | ″ | ″ | symptomatology |
168 | ″ | ″ | symptoms |
169 | ″ | ″ | system |
170 | ″ | ″ | thirty minutes |
171 | ″ | ″ | total |
172 | ″ | ″ | treatment |
173 | ″ | ″ | trials |
174 | ″ | ″ | use |
175 | ″ | ″ | usual care |
176 | ″ | ″ | usual care arm |
177 | ″ | ″ | utility |
178 | ″ | ″ | v2.1 |
179 | ″ | ″ | ventilatory support |
180 | ″ | ″ | version 3.0 |
181 | ″ | ″ | video |
182 | ″ | ″ | web-based system |
183 | ″ | ″ | websites |
184 | ″ | ″ | weeks |
185 | ″ | ″ | work status |
186 | ″ | ″ | years |
187 | ″ | schema:name | Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN’ (REGAIN): a structured summary of a study protocol for a randomised controlled trial |
188 | ″ | schema:pagination | 8 |
189 | ″ | schema:productId | N36e5300bb797486ea1db8fbf3d76dd57 |
190 | ″ | ″ | N49f9728ebd364b93859fb7a4ea6d52a5 |
191 | ″ | ″ | Nf89061c09e494d24a824ae3004185a34 |
192 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1134396148 |
193 | ″ | ″ | https://doi.org/10.1186/s13063-020-04978-9 |
194 | ″ | schema:sdDatePublished | 2022-05-20T07:38 |
195 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
196 | ″ | schema:sdPublisher | N57c235471ee94df68d2cbb55b8b37eed |
197 | ″ | schema:url | https://doi.org/10.1186/s13063-020-04978-9 |
198 | ″ | sgo:license | sg:explorer/license/ |
199 | ″ | sgo:sdDataset | articles |
200 | ″ | rdf:type | schema:ScholarlyArticle |
201 | N096603d874624273bbd735f57ab61f8b | rdf:first | sg:person.01045156011.03 |
202 | ″ | rdf:rest | N7ba37b6c2bb14305a743fc024c0ee2ed |
203 | N0d26e3b5945d43f6a97893f7221b7653 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
204 | ″ | schema:name | Quality of Life |
205 | ″ | rdf:type | schema:DefinedTerm |
206 | N0d479ad4c8ae4801adeb1f221185f47c | rdf:first | sg:person.016564201567.78 |
207 | ″ | rdf:rest | N3b4aee0d7acf4f17abf5670d1a3e6f00 |
208 | N13ba09f8cbed4231acecad51b079eb34 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
209 | ″ | schema:name | Severity of Illness Index |
210 | ″ | rdf:type | schema:DefinedTerm |
211 | N15a7522317cc4394989a45305f32ba12 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
212 | ″ | schema:name | Randomized Controlled Trials as Topic |
213 | ″ | rdf:type | schema:DefinedTerm |
214 | N15e0adf1520f4a75a3e41cc2226579d6 | rdf:first | sg:person.01131751765.75 |
215 | ″ | rdf:rest | N402af146b5384d4a9507485e99938ad8 |
216 | N1c7f8897ae9a40ffb427e38c558e5b84 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
217 | ″ | schema:name | Exercise Therapy |
218 | ″ | rdf:type | schema:DefinedTerm |
219 | N22d6066a6ea94cba8ab5f23e8984bf78 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
220 | ″ | schema:name | Multicenter Studies as Topic |
221 | ″ | rdf:type | schema:DefinedTerm |
222 | N2335dcb88a8e4073acd08e0ff6074104 | rdf:first | sg:person.010243472167.53 |
223 | ″ | rdf:rest | N15e0adf1520f4a75a3e41cc2226579d6 |
224 | N355e0d2fa3f84b1c90098149f8b27ba4 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
225 | ″ | schema:name | Humans |
226 | ″ | rdf:type | schema:DefinedTerm |
227 | N36e5300bb797486ea1db8fbf3d76dd57 | schema:name | doi |
228 | ″ | schema:value | 10.1186/s13063-020-04978-9 |
229 | ″ | rdf:type | schema:PropertyValue |
230 | N3735dd1716f94ce5988ce431deb8afcf | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
231 | ″ | schema:name | Cost-Benefit Analysis |
232 | ″ | rdf:type | schema:DefinedTerm |
233 | N3b4aee0d7acf4f17abf5670d1a3e6f00 | rdf:first | sg:person.01306423733.58 |
234 | ″ | rdf:rest | Nbac4303759524a3d8e14a884a64b8b4e |
235 | N402af146b5384d4a9507485e99938ad8 | rdf:first | sg:person.01160453144.93 |
236 | ″ | rdf:rest | N80f71139d2d34ad2be12caf2a8043940 |
237 | N42ff5b8ddd69490c90ff247c083f5e6c | rdf:first | sg:person.0734523032.67 |
238 | ″ | rdf:rest | Nd508feafb56748d78a856a34437af8b2 |
239 | N470a9988d41b4ead9d5eb7685cb4566a | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
240 | ″ | schema:name | SARS-CoV-2 |
241 | ″ | rdf:type | schema:DefinedTerm |
242 | N49f9728ebd364b93859fb7a4ea6d52a5 | schema:name | pubmed_id |
243 | ″ | schema:value | 33407804 |
244 | ″ | rdf:type | schema:PropertyValue |
245 | N4a7f145bf9f1439a849f63867bd07f01 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
246 | ″ | schema:name | Internet-Based Intervention |
247 | ″ | rdf:type | schema:DefinedTerm |
248 | N4e81f50ce9b941a6a93d2f0a39e9f7ac | rdf:first | sg:person.014740563567.08 |
249 | ″ | rdf:rest | N61fa8e26843341e8a6dddd72ac9a75fc |
250 | N57c235471ee94df68d2cbb55b8b37eed | schema:name | Springer Nature - SN SciGraph project |
251 | ″ | rdf:type | schema:Organization |
252 | N586191abdeb1438da99d8d6c6e8609d2 | rdf:first | sg:person.01233634045.14 |
253 | ″ | rdf:rest | N42ff5b8ddd69490c90ff247c083f5e6c |
254 | N61d378f5cfcc4022bffa856abf92e671 | rdf:first | sg:person.0713712645.25 |
255 | ″ | rdf:rest | N096603d874624273bbd735f57ab61f8b |
256 | N61fa8e26843341e8a6dddd72ac9a75fc | rdf:first | sg:person.011223414367.51 |
257 | ″ | rdf:rest | N7a3a9654f16d46a7806850dcb0e41092 |
258 | N79a258beb5974ab9ab1ebd590e0a978d | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
259 | ″ | schema:name | Psychosocial Support Systems |
260 | ″ | rdf:type | schema:DefinedTerm |
261 | N7a024ac39b62440a8212234a4e13dc9d | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
262 | ″ | schema:name | Female |
263 | ″ | rdf:type | schema:DefinedTerm |
264 | N7a3a9654f16d46a7806850dcb0e41092 | rdf:first | sg:person.01246242076.49 |
265 | ″ | rdf:rest | N7b56f93a1a4641e48beab954c304023e |
266 | N7aa9f214aba04eada24eafb2990bd6bf | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
267 | ″ | schema:name | Referral and Consultation |
268 | ″ | rdf:type | schema:DefinedTerm |
269 | N7b56f93a1a4641e48beab954c304023e | rdf:first | sg:person.013462051167.80 |
270 | ″ | rdf:rest | N95c0c8f364134ed0a2dcdadca199fe19 |
271 | N7ba37b6c2bb14305a743fc024c0ee2ed | rdf:first | sg:person.01237606430.13 |
272 | ″ | rdf:rest | rdf:nil |
273 | N7cd10b0bcacd4dc78f69ef819b3dfe37 | rdf:first | sg:person.013000717167.21 |
274 | ″ | rdf:rest | N0d479ad4c8ae4801adeb1f221185f47c |
275 | N80f71139d2d34ad2be12caf2a8043940 | rdf:first | sg:person.010357720567.21 |
276 | ″ | rdf:rest | N4e81f50ce9b941a6a93d2f0a39e9f7ac |
277 | N8718a97f4b4d48fe935fb913bd3653ed | schema:volumeNumber | 22 |
278 | ″ | rdf:type | schema:PublicationVolume |
279 | N8913d27f73734ccca79baaf7915abad2 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
280 | ″ | schema:name | Male |
281 | ″ | rdf:type | schema:DefinedTerm |
282 | N91d9a4b51926418fa27b3758b796c53b | rdf:first | sg:person.0615465711.50 |
283 | ″ | rdf:rest | Nabb54fe6dc3d485ba3bdd200289f9a6b |
284 | N95c0c8f364134ed0a2dcdadca199fe19 | rdf:first | sg:person.011660466171.45 |
285 | ″ | rdf:rest | N91d9a4b51926418fa27b3758b796c53b |
286 | N98092d922f0f4afe9f8833fd52d0ed7e | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
287 | ″ | schema:name | Adult |
288 | ″ | rdf:type | schema:DefinedTerm |
289 | Nabb54fe6dc3d485ba3bdd200289f9a6b | rdf:first | sg:person.014701743302.20 |
290 | ″ | rdf:rest | N7cd10b0bcacd4dc78f69ef819b3dfe37 |
291 | Nac7ca32b35814e0abb46364f7df3ccde | schema:issueNumber | 1 |
292 | ″ | rdf:type | schema:PublicationIssue |
293 | Nbac4303759524a3d8e14a884a64b8b4e | rdf:first | sg:person.0700753524.38 |
294 | ″ | rdf:rest | N61d378f5cfcc4022bffa856abf92e671 |
295 | Nc0ba816774c54ca48c04fdeee75e6d1d | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
296 | ″ | schema:name | COVID-19 |
297 | ″ | rdf:type | schema:DefinedTerm |
298 | Nd2702ab4846949ae8ea3f175dd2732bc | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
299 | ″ | schema:name | United Kingdom |
300 | ″ | rdf:type | schema:DefinedTerm |
301 | Nd508feafb56748d78a856a34437af8b2 | rdf:first | sg:person.01255212333.07 |
302 | ″ | rdf:rest | N2335dcb88a8e4073acd08e0ff6074104 |
303 | Nd6cef0aeda184dc190db78152c49f9fe | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
304 | ″ | schema:name | Treatment Outcome |
305 | ″ | rdf:type | schema:DefinedTerm |
306 | Nf89061c09e494d24a824ae3004185a34 | schema:name | dimensions_id |
307 | ″ | schema:value | pub.1134396148 |
308 | ″ | rdf:type | schema:PropertyValue |
309 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
310 | ″ | schema:name | Medical and Health Sciences |
311 | ″ | rdf:type | schema:DefinedTerm |
312 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
313 | ″ | schema:name | Clinical Sciences |
314 | ″ | rdf:type | schema:DefinedTerm |
315 | anzsrc-for:1117 | schema:inDefinedTermSet | anzsrc-for: |
316 | ″ | schema:name | Public Health and Health Services |
317 | ″ | rdf:type | schema:DefinedTerm |
318 | sg:grant.9613934 | http://pending.schema.org/fundedItem | sg:pub.10.1186/s13063-020-04978-9 |
319 | ″ | rdf:type | schema:MonetaryGrant |
320 | sg:journal.1297400 | schema:issn | 1468-6708 |
321 | ″ | ″ | 1745-6215 |
322 | ″ | schema:name | Trials |
323 | ″ | schema:publisher | Springer Nature |
324 | ″ | rdf:type | schema:Periodical |
325 | sg:person.010243472167.53 | schema:affiliation | grid-institutes:None |
326 | ″ | schema:familyName | Sheehan |
327 | ″ | schema:givenName | Bartholomew |
328 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010243472167.53 |
329 | ″ | rdf:type | schema:Person |
330 | sg:person.010357720567.21 | schema:affiliation | grid-institutes:None |
331 | ″ | schema:familyName | Jones |
332 | ″ | schema:givenName | Christina |
333 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010357720567.21 |
334 | ″ | rdf:type | schema:Person |
335 | sg:person.01045156011.03 | schema:affiliation | grid-institutes:grid.7372.1 |
336 | ″ | schema:familyName | Seers |
337 | ″ | schema:givenName | Kate |
338 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045156011.03 |
339 | ″ | rdf:type | schema:Person |
340 | sg:person.011223414367.51 | schema:affiliation | grid-institutes:grid.7372.1 |
341 | ″ | schema:familyName | Smith |
342 | ″ | schema:givenName | Jessica |
343 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011223414367.51 |
344 | ″ | rdf:type | schema:Person |
345 | sg:person.01131751765.75 | schema:affiliation | grid-institutes:grid.15628.38 |
346 | ″ | schema:familyName | McWilliams |
347 | ″ | schema:givenName | David |
348 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131751765.75 |
349 | ″ | rdf:type | schema:Person |
350 | sg:person.01160453144.93 | schema:affiliation | grid-institutes:grid.412563.7 |
351 | ″ | schema:familyName | Yeung |
352 | ″ | schema:givenName | Joyce |
353 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160453144.93 |
354 | ″ | rdf:type | schema:Person |
355 | sg:person.011660466171.45 | schema:affiliation | grid-institutes:grid.7372.1 |
356 | ″ | schema:familyName | Ennis |
357 | ″ | schema:givenName | Stuart |
358 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011660466171.45 |
359 | ″ | rdf:type | schema:Person |
360 | sg:person.01233634045.14 | schema:affiliation | grid-institutes:grid.8096.7 |
361 | ″ | schema:familyName | McGregor |
362 | ″ | schema:givenName | Gordon |
363 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233634045.14 |
364 | ″ | rdf:type | schema:Person |
365 | sg:person.01237606430.13 | schema:affiliation | grid-institutes:grid.7372.1 |
366 | ″ | schema:familyName | Underwood |
367 | ″ | schema:givenName | Martin |
368 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237606430.13 |
369 | ″ | rdf:type | schema:Person |
370 | sg:person.01246242076.49 | schema:affiliation | grid-institutes:grid.7372.1 |
371 | ″ | schema:familyName | Ji |
372 | ″ | schema:givenName | Chen |
373 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246242076.49 |
374 | ″ | rdf:type | schema:Person |
375 | sg:person.01255212333.07 | schema:affiliation | grid-institutes:grid.7372.1 |
376 | ″ | schema:familyName | Bruce |
377 | ″ | schema:givenName | Julie |
378 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255212333.07 |
379 | ″ | rdf:type | schema:Person |
380 | sg:person.013000717167.21 | schema:affiliation | grid-institutes:grid.7372.1 |
381 | ″ | schema:familyName | Guck |
382 | ″ | schema:givenName | Jonathan |
383 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013000717167.21 |
384 | ″ | rdf:type | schema:Person |
385 | sg:person.01306423733.58 | schema:affiliation | grid-institutes:grid.7372.1 |
386 | ″ | schema:familyName | Potter |
387 | ″ | schema:givenName | Rachel |
388 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306423733.58 |
389 | ″ | rdf:type | schema:Person |
390 | sg:person.013462051167.80 | schema:affiliation | grid-institutes:None |
391 | ″ | schema:familyName | Fairbrother |
392 | ″ | schema:givenName | Elaine |
393 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013462051167.80 |
394 | ″ | rdf:type | schema:Person |
395 | sg:person.014701743302.20 | schema:affiliation | grid-institutes:grid.7372.1 |
396 | ″ | schema:familyName | Alleyne |
397 | ″ | schema:givenName | Sharisse |
398 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014701743302.20 |
399 | ″ | rdf:type | schema:Person |
400 | sg:person.014740563567.08 | schema:affiliation | grid-institutes:grid.15628.38 |
401 | ″ | schema:familyName | Lara |
402 | ″ | schema:givenName | Beatriz |
403 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014740563567.08 |
404 | ″ | rdf:type | schema:Person |
405 | sg:person.016564201567.78 | schema:affiliation | grid-institutes:grid.7372.1 |
406 | ″ | schema:familyName | Padfield |
407 | ″ | schema:givenName | Emma |
408 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016564201567.78 |
409 | ″ | rdf:type | schema:Person |
410 | sg:person.0615465711.50 | schema:affiliation | grid-institutes:grid.7372.1 |
411 | ″ | schema:familyName | Heine |
412 | ″ | schema:givenName | Peter |
413 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615465711.50 |
414 | ″ | rdf:type | schema:Person |
415 | sg:person.0700753524.38 | schema:affiliation | grid-institutes:grid.7372.1 |
416 | ″ | schema:familyName | Mason |
417 | ″ | schema:givenName | James |
418 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700753524.38 |
419 | ″ | rdf:type | schema:Person |
420 | sg:person.0713712645.25 | schema:affiliation | grid-institutes:grid.7372.1 |
421 | ″ | schema:familyName | Lall |
422 | ″ | schema:givenName | Ranjit |
423 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713712645.25 |
424 | ″ | rdf:type | schema:Person |
425 | sg:person.0734523032.67 | schema:affiliation | grid-institutes:grid.7372.1 |
426 | ″ | schema:familyName | Sandhu |
427 | ″ | schema:givenName | Harbinder |
428 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734523032.67 |
429 | ″ | rdf:type | schema:Person |
430 | grid-institutes:None | schema:alternateName | Coventry & Warwickshire Partnership Trust, Coventry, UK |
431 | ″ | ″ | ICUSteps, Kemp House, London, UK |
432 | ″ | ″ | Patient & Public Involvement Representative, Coventry, UK |
433 | ″ | schema:name | Coventry & Warwickshire Partnership Trust, Coventry, UK |
434 | ″ | ″ | ICUSteps, Kemp House, London, UK |
435 | ″ | ″ | Patient & Public Involvement Representative, Coventry, UK |
436 | ″ | rdf:type | schema:Organization |
437 | grid-institutes:grid.15628.38 | schema:alternateName | Centre for Care Excellence, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK |
438 | ″ | ″ | Department of Respiratory Medicine, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK |
439 | ″ | schema:name | Centre for Care Excellence, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK |
440 | ″ | ″ | Department of Respiratory Medicine, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK |
441 | ″ | rdf:type | schema:Organization |
442 | grid-institutes:grid.412563.7 | schema:alternateName | Department of Anaesthesia and Critical Care, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK |
443 | ″ | schema:name | Department of Anaesthesia and Critical Care, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK |
444 | ″ | ″ | Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK |
445 | ″ | rdf:type | schema:Organization |
446 | grid-institutes:grid.7372.1 | schema:alternateName | Centre for Health Economics at Warwick, Warwick Medical School, University of Warwick, Coventry, UK |
447 | ″ | ″ | Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK |
448 | ″ | ″ | Warwick Research in Nursing, Warwick Medical School, University of Warwick, Coventry, UK |
449 | ″ | schema:name | Centre for Health Economics at Warwick, Warwick Medical School, University of Warwick, Coventry, UK |
450 | ″ | ″ | Department of Cardiopulmonary Rehabilitation, Centre for Exercise & Health, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK |
451 | ″ | ″ | Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK |
452 | ″ | ″ | Warwick Research in Nursing, Warwick Medical School, University of Warwick, Coventry, UK |
453 | ″ | rdf:type | schema:Organization |
454 | grid-institutes:grid.8096.7 | schema:alternateName | Centre for Sport, Exercise & Life Sciences, Coventry University, Coventry, UK |
455 | ″ | schema:name | Centre for Sport, Exercise & Life Sciences, Coventry University, Coventry, UK |
456 | ″ | ″ | Department of Cardiopulmonary Rehabilitation, Centre for Exercise & Health, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK |
457 | ″ | ″ | Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK |
458 | ″ | rdf:type | schema:Organization |